| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |